3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Breast Neoplasms
1
Interventions
Docetaxel
43
enzalutamide
31
Prednisone
25
Abiraterone Acetate
24
Magnetic Resonance Spectroscopy
18
abiraterone
15
pembrolizumab
14
bicalutamide
14
Radiotherapy
14
Cyclophosphamide
14
darolutamide
12
Leuprolide
12
Goserelin
12
apalutamide
10
Ipilimumab
10
Injections
10
olaparib
9
Specimen Handling
9
Radiosurgery
9
Radiation
9
Biopsy
9
Pluvicto
8
Paclitaxel
8
fludarabine
7
Radiotherapy, Intensity-Modulated
7
Carboplatin
7
sargramostim
6
cabazitaxel
6
Sirolimus
6
Nivolumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Prostatic Neoplasms
×
irosustat
×
Clear all
NCT00790374
2019-01-15
STX64PC
Ipsen
Phase 1
Completed
17 enrolled